NUTRACEUTICAL INTERNATIONAL CORP
DelistedCIK 1050007fmd_0VQ5HY0DX7WXK4EP4SC1ZNDBMHManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Oct 01, 2008 to Jun 30, 2017, 30 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 162 | 180 | 188 | 200 | 208 | 214 | 216 | 233 |
| Cost of revenue | 77 | 86 | 93 | 100 | 106 | 108 | 110 | 115 |
| Gross profit | 85 | 94 | 95 | 100 | 103 | 106 | 106 | 118 |
| Research and development | – | 4 | 4 | 4 | 3 | 4 | 4 | 4 |
| Selling, general and administrative | 62 | 66 | 68 | 71 | 72 | 77 | 77 | 85 |
| Total operating expenses | 101 | 67 | 70 | 74 | 75 | 80 | 82 | 89 |
| Operating income | (16) | 27 | 25 | 26 | 28 | 26 | 24 | 29 |
| Interest expense | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Income before taxes | (17) | 26 | 24 | 24 | 27 | 25 | 23 | 28 |
| Income tax expense | (3) | 10 | 8 | 8 | 10 | 9 | 8 | 9 |
| Net income from continuing operations | (15) | 16 | 16 | 16 | 17 | 16 | 15 | 19 |
| Net income to common shareholders | (15) | 16 | 16 | 16 | 17 | 16 | 15 | 19 |